12-Jan-2026
Globe Newswire (Mon, 12-Jan 7:00 AM ET)
Sharps Technology Reports Strong Growth in Q3 2025 as it Advances Execution of Treasury Strategy
Globe Newswire (Mon, 17-Nov 7:00 AM ET)
Market Chameleon (Thu, 2-Oct 3:36 AM ET)
Market Chameleon (Mon, 29-Sep 3:37 AM ET)
Market Chameleon (Tue, 23-Sep 3:31 AM ET)
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.
Sharps Technology trades on the NASDAQ stock market under the symbol STSS.
As of January 12, 2026, STSS stock price climbed to $2.03 with 1,338,626 million shares trading.
STSS has a beta of 2.92, meaning it tends to be more sensitive to market movements. STSS has a correlation of 0.04 to the broad based SPY ETF.
STSS has a market cap of $58.86 million. This is considered a Micro Cap stock.
In the last 3 years, STSS traded as high as $13,463.87 and as low as $1.65.
The top ETF exchange traded funds that STSS belongs to (by Net Assets): VXF.
STSS has underperformed the market in the last year with a price return of -99.7% while the SPY ETF gained +19.2%. STSS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -69.8% and -8.6%, respectively, while the SPY returned +3.9% and +0.7%, respectively.
STSS support price is $1.70 and resistance is $2.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that STSS shares will trade within this expected range on the day.